REDCARE PHARMACY N.V.

Remuneration Policy of the Supervisory Board

1. ADOPTION, CHANGES FROM PREVIOUS POLICY , AMENDMENTS, DEVIATIONS AND PERIODIC REVIEW

Adoption

  1. The existing remuneration policy for Redcare Pharmacy N.V. and its subsidiaries (together, the "Company"), covering the supervisory board (raad van commissarissen) of the Company (the "Supervisory Board ") was adopted by the general meeting of the Company (the "General Meeting") at the annual general meeting held on 14 April 2022 (the "2022 Remuneration Policy ").
  2. This proposed revised policy (the "Remuneration Policy ") has been proposed by the Supervisory Board and is presented to be adopted by the General Meeting at the annual general meeting (such meeting, an "AGM") to be held on 17 April 2024. If approved, this Remuneration Policy will replace the 2022 Remuneration Policy of the Supervisory Board as of the Effective Date (vide 1.5).

Changes compared to Previous Policy

1.3 The following describes the changes compared to the previous version of Remuneration Policy of the Supervisory Board:

  1. Reimbursement of reasonable travel expenses (vide 2.7); and
  2. Eligibility for multiple committee membership fees for all Supervisory Board members (including Chairman and Vice-Chairman) (vide 2.10).

Effective Date and Amendments

  1. This Remuneration Policy, once approved by the General Meeting at the annual general meeting on 17 April 2024, may only be amended by the General Meeting pursuant to a proposal of the Supervisory Board.
  2. The effective date of this Remuneration Policy is 1 January 2024 (the "Effective Date "), i.e., the stipulations of this revised Remuneration Policy will apply to all remuneration components awarded on or after 1 January 2024. This Remuneration Policy will remain in effect for four years, up to and including the date of the AGM to be held in 2028, or, if earlier, until a revised Remuneration Policy has been approved by the General Meeting in accordance with paragraph 1.4. Any material changes to this Remuneration Policy will be submitted to the General Meeting for approval, together with a description and explanation of the material change(s). If the General Meeting does not approve the proposed changes to this Remuneration Policy, the existing Remuneration Policy will continue to apply.

Deviations

  1. With respect to the remuneration of the Supervisory Board, the Supervisory Board may, in exceptional circumstances only and in accordance with Dutch law, decide to temporarily deviate from any provision of this Remuneration Policy.
  2. Exceptional circumstances will only cover situations in which the deviation from a provision of this Remuneration Policy is necessary (i) to ensure the long-term interests and sustainability of the Company, or (ii) to assure the Company's viability, such as a change of control at the level of the Company.
  3. The Supervisory Board will account and retroactively seek approval of the General Meeting for any deviation from a provision of this Remuneration Policy at the next AGM, i.e. the AGM to be held after the occurrence of the exceptional circumstance that resulted in a deviation from this Remuneration Policy.

Periodic Review

1.9 The Supervisory Board strives to keep this Remuneration Policy up to date with market circumstances and developments as well as any new or changed requirements set by applicable laws. This Remuneration Policy will be reviewed periodically by the Supervisory Board.

2. REMUNERATION POLICY FOR THE SUPERVISORY BOARD

Authority

  1. The remuneration of the individual members of the Supervisory Board is determined by the General Meeting.
  2. Any proposed material changes to the compensation structure or elements for the Supervisory Board set forth in this Remuneration Policy, will be submitted to the General Meeting for approval.

Objectives and principles

  1. This Remuneration Policy aims to attract and retain members of the Supervisory Board with the required background, skills and experience
  2. The remuneration of the members of the Supervisory Board will:
    1. be set at a level which is considered appropriate to attract individuals with the necessary international experience and ability to make an important contribution to the Company's business and operations;
    2. consider the level of responsibility of each Supervisory Board member and the remuneration paid by other European headquartered companies of similar scale listed on a European regulated market;
    3. be designed to fairly compensate the members of the Supervisory Board and reflects the time spent in, and the responsibilities of, each of their roles;

Page 2/4

  1. be based on fixed amounts paid in cash; and
  2. be regularly assessed against European market levels.

2.5 The compensation for the Supervisory Board set forth in this Remuneration Policy is designed to ensure the independence of the members of the Supervisory Board and their effectiveness from a corporate governance perspective.

Fixed compensation (annual base fee)

  1. All members of the Supervisory Board are paid a fixed annual base fee to compensate them for their services for the Company.
  2. The Company will reimburse reasonable travel and accommodation expenses actually incurred by the members of the Supervisory Board when performing their services for the Company. Reasonable travel costs are costs equal to the costs that would be incurred for travelling from a member's home to the location where the services are provided, with the understanding that travel may also be from elsewhere to the location. All travel will be conducted in accordance with the applicable Company's travel policy and sustainability considerations.
  3. The fixed compensation paid to the members of the Supervisory Board is not linked to the financial results of the Company. Furthermore, the members of the Supervisory Board do not (i) receive any performance related remuneration or remuneration in the form of shares in the share capital of the Company or stock options, or (ii) accrue any pension rights with the Company. In accordance with the Dutch Corporate Governance Code, any shares in the share capital of the Company held by a member of the Supervisory Board will be a long-term investment. Any trading in the Company's shares by the Supervisory Board members will be done in compliance with the Company's insider trading policy and observance of any closed periods. In addition to a fixed fee, the members of the Supervisory Board are provided with a committee fee. Payment is done in Euro. Currency conversion risks are for the account of the member of the Supervisory Board.
  4. Fixed compensation:

Chairman Supervisory Board

€ 80,000

Vice-Chairman Supervisory Board

€ 60,000

Member Supervisory Board

€ 40,000

Page 3/4

Committee membership fees

2.10 In addition to the fixed compensation outlined in section 2.9, members of the Supervisory Board committees receive a supplementary committee fee provided that the committee must have met at least once during the fiscal year. Supervisory Board members are eligible for multiple committee fees in case of multiple committee memberships:

Chairman Audit Committee

12,000

Member of Audit Committee

8,000

Chairman other committee

9,000

Member other committee

6,000

Remuneration for Supervisory Board or Supervisory Board committee joiners or leavers

2.11 If a Supervisory Board member joins or leaves the Supervisory Board or a position in one of the Supervisory Board committees, during the course of a financial year, they receive their remuneration on a pro-rated basis. Pro-rated remuneration for committee work is subject to the condition that the Supervisory Board committee must have met at least once before a member's departure.

Service agreements and severance arrangements

2.12 Currently, none of the members of the Supervisory Board has a service agreement with the Company and, therefore, no severance arrangements are in place for the Supervisory Board members.

Loans

2.13 The Company does not provide any personal loans, advance payments or guarantees to the members of the Supervisory Board.

Page 4/4

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Redcare Pharmacy NV published this content on 17 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 April 2024 17:06:08 UTC.